View Article

Abstract

The detection and characterization of impurities in pharmaceuticals are pivotal aspects of ensuring the safety, efficacy, and quality of drug products. This review provides a comprehensive overview of the analytical techniques employed in the identification and quantification of impurities at various stages of pharmaceutical development, manufacturing, and quality control. Chromatographic methods, including High-Performance Liquid Chromatography (HPLC) and Gas Chromatography (GC), are foundational for their ability to separate complex mixtures. Mass spectrometry (MS) and Nuclear Magnetic Resonance (NMR) spectroscopy offer high sensitivity and structural insights crucial for impurity characterization. The integration of these techniques, such as in Liquid Chromatography-Mass Spectrometry (LC-MS) and Liquid Chromatography-Nuclear Magnetic Resonance (LC-NMR), provides a synergistic approach to impurity analysis. Advanced hyphenated techniques enhance specificity and accuracy, allowing for real-time monitoring and dynamic adjustments during analysis. Challenges in chiral separation, degradation product analysis, and method validation are addressed through the sophistication of these methodologies. The review underscores the significance of data analysis and validation processes, ensuring the reliability of results in compliance with stringent regulatory standards. Overall, the continuous evolution and integration of analytical techniques play a pivotal role in shaping the future of pharmaceutical research, development, and quality assurance, emphasizing the commitment to producing pharmaceuticals of the highest quality and safety standards.

Keywords

Impurities, Hyphenated Techniques, Active Pharmaceutical Ingredients, Chromatography, Analytical Technique, Detection

Reference

  1. U.S. Food and Drug Administration. Guidance for Industry, Q3A Impurities in New Drug Substances. February 2003.
  2. U.S. Food and Drug Administration. Guidance for Industry, Q3B Impurities in New Drug Products. July 2006.
  3. Pallavi Palkhe Shilpa Kawade, International journal of chemical studies, review on hyphenated techniques, department of vhemisTrysinhgad College of pharmacy vadgaonpune
  4. Hyphenated NMR techniques Julie R. KESTING, Kenneth T. JOHANSzN and Jerzy W. JAROSZEWSKI Department of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Denmark.
  5. Masoom Raza Siddiqui , Zeid A. AlOthman , Nafisur Rahman Arabian journal of chemistry, Analytical techniques in pharmaceutical analysis Department of Chemistry, Aligarh Muslim University, Aligarh (UP) 202002, India
  6. Wilson ID, Brinkman UA. Hyphenation and hyper nation: The Practice and Prospects of Multiple Hyphenation. J Chromatogr A, 2003; 1000: 325-56.
  7. . Szpunar J, Lobinski R, Prange A. Hyphenated Techniques for Elemental speciation in Biological Systems. Applspect, 2003; 57(3): 102A-12A.
  8. Joshi RR, Gupta KR, Patil SS. Hyphenated Technique- A Boon To Analytical World. IJPSR, 2012; 3(11): 4184-91
  9. Ahuja S. Impurities Evaluation of Pharmaceuticals, Marcel Dekker, Inc. New York, 2006.
  10. 15. Guntupalli S, Ray UK, Murali N, Gupta PB, Kumar VJ, Satheesh D, et al. Identification, isolation and characterization of process related impurities in ezetimibe. J Pharm Biomed Anal 2014;88:385-90.
  11. Prakash L, Malipeddi H, Subbaiah BV, Lakka NS. Impurity profiling and stability-indicating UPLC method development and validation for the estimation of related impurities of halobetasol propionate in halobetasol propionate 0.05 % (w/w) cream. J Chromatogr Sci 2015;53(1):112-21.
  12. Lajin B, Steiner O, Fasshold L, Zangger K, Goessler W. The identification and chromatographic separation of a new highly analogous impurity of the active pharmaceutical ingredient icatibant. Eur J Pharm Sci 2019;132:121-124.
  13. Kumar V, Bhurta D, Sharma A, Kumar P, Bharate SB, Vishwakarma RA, et al. Impurity profiling of anticancer preclinical candidate, IIIM-290. J Pharm Biomed Anal 2019;166:1-5.
  14. Prakash L, Himaja M, Subbaiah BV, Vasudev R, Srinivasulu C, Haribabu R. Isolation, identification and characterization of degradant impurities in Tolterodine tartrate formulation. J Pharm Biomed Anal 2014;90:215-221.
  15. Zhuang T, Zhang W, Cao L, He K, Wang Y, Li J, et al. Isolation, identification and characterization of two novel process-related impurities in olanzapine. J Pharm Biomed Anal 2018;152:188- 96.
  16. Kumar N, Devineni SR, Gajjala PR, Dubey SK, Kumar P. Synthesis, isolation, identification and characterization of new process-related impurity in isoproterenol hydrochloride by HPLC, LC/ESI-MS and NMR. J Pharm Anal 2017;7(6):394- 400.
  17. Karthikeyan K, Arularasu GT, Murali V, Pillai KC. Identification, isolation, characterization and response factor determination of process-related impurity in meprobamate drug substance. J Pharm Biomed Anal 2011;54(1):208-212.
  18. Reddy RB, More KR, Gupta L, Jha MS, Magar L. Identification, synthesis, isolation and characterization of new impurity in metoprolol tartrate tablets. J Pharm Biomed Anal 2016;117:104-8
  19. Darcsi A, Tóth G, Kökösi J, Béni S. Structure elucidation of a process-related impurity of dapoxetine. J Pharm Biomed Anal 2014;96:272-277.
  20. Reddy GV, Reddy BV, Haque SW, Gautam HD, Kumar P, Kumar AP, et al. Development and validation of a stabilityindicating UPLC method for rosuvastatin and its related impurities in pharmaceutical dosage forms. Quimica Nova 2011;34(2):250-5.
  21. Reddy GR, Kumar AP, Ram Reddy BV, Sreeramulu J. Application of ion-trap mass spectrometry for identification and structural determination of an unknown impurity in simvastatin. Pharmazie 2009;64(10):638-41.
  22. Ram Reddy GV, Kumar AP, Venkateswara Reddy B, Sreeramulu J, Park JH. Separation, identification and structural elucidation of a new impurity in the drug substance of amlodipine maleate using LC-MS/MS, NMR and IR. Croat Chem Acta 2010;83(4):443-9.
  23. Venkateswara Reddy B, Kumar AP, Ram Reddy GV, Sahai M, Sreeramulu J, Park JH. Stability indicating reversedphase high performance liquid chromatography method for determination of impurities in ofloxacin tablet formulations. Anal Lett 2010;43(17):2653-62.
  24. Sutar N, Garai R, Sharma US, Sharma UK. Anthelmintic activity of Platycladusorientalis leaves extract. Int. J. Parasitol. Res., 2010; 2(2): 1-3.
  25. Parimoo P, et al, A Text Book of Pharmaceutical Analysis, CBS Publishers, New Delhi: 1998; 14.
  26. Conte E, Milani R, Morali G, Abballe F. Comparison between accelerated solvent extraction and traditional extraction methods for the analysis of the herbicide diflufenican in soil. J Chromatogr A 1997;765(1):121-5.
  27. Szepesi, G., Nyiredy, S., 1996. Pharmaceutical and drugs. In: Sherma, J., Fried, B. (Eds.), Handbook of Thin-Layer Chromatography, 2nd ed. Marcel Dekker, New York, pp. 208–235.
  28. Cimpoiu, C., Hosu, A., Hodison, S., 2006. J. Pharm. Biomed. Anal. 41, 633–637.
  29. Gumieniczek, A., Hopkala, H., Bereka, A., 2004. J. Liq. Chromatogr. Relat. Technol. 27, 2057–2070.
  30. Bebawy, L.I., Moustafa, A.A., Abo-Talib, N.F., 2002. J. Pharm. Biomed Anal. 27, 779–793.
  31. Ashour, A., Hegazy, M.A.M., Moustafa, A.A., Kelani, K.O., Abdel Fattah, L.E., 2009. Drug Test. Anal. 1, 327–338.
  32. White, D., Varlashkin, P., Rusch, D.N., 1992. J. Pharm. Sci. 81, 1204–1209.
  33. Agbaba, D., Radovic, A., Vladimirov, S., Zivanov-Stakic, D., 1996. J. Chromatogr. Sci. 34, 460–464.
  34. Watson, D.G., 1999. Pharmaceutical Analysis. Churchill Livingstone, Edinburg, p. 208.
  35. Lima, E.M., Almeida Diniz, D.G., Antoniosi-Filho, N.R., 2005. J. Pharm. Biomed. Anal. 38, 678–685
  36. Zuo, Y., Zhang, L., Wu, J., Fritz, J.W., Medeiros, S., Rego, C., 2004. Anal. Chim. Acta 526, 35–39.
  37. Somuramasami, J., Wei, Y.-C., Soliman, E.F., Rustum, A.M., 2011. J. Pharm. Biomed. Anal. 54, 242–247.
  38. Frost, R.P., Hussain, M.S., Raghani, A.R., 2003. J. Sep. Sci. 26, 1097-1011.
  39. Hiriyanna, S.G., Basavaiah, K., 2008. J. Brazil Chem. Soc. 19, 397– 404.
  40. Reddy, B.P., Reddy, M.S., 2009. Int. Pharm. Tech. Res. 1, 230–234.
  41. Hashimoto, K., Urakami, K., Fujiwara, Y., Terada, S., Watanabe, C., 2001. Anal. Sci. 17, 645–648
  42. Saraji, M., Khayamian, T., Siahpoosh, Z.H., Farajmand, B., 2012. Anal. Methods 2012 (4), 1552–1559.
  43. Deconinck, E., Canfyn, M., Sacre´, P.-Y., Baudewyns, S., Courselle, P., De Beer, J.O., 2012. J. Pharm. Biomed. Anal. 70, 64–70.
  44. Look DC, Jones RL, Cantwell G. Characterization of homoepitaxial p­type ZnO grown by molecular beam epitaxy. Appl Phys Lett. 2002?81:1830.
  45. Rao RN, Nagaraju V.An overview of the recent trends in development of HPLC methods for determination of impurities in drugs. J Pharm Biomed Anal 2003;33(3):335-77.
  46. Vassort A, Barrett DA, Shaw PN, Ferguson PD, Szucs R. A generic approach to the impurity profiling of drugs using standardized and independent capillary zone electrophoresis methods coupled to electrospray ionization mass spectrometry. Electrophoresis 2005;26(9):1712-23.
  47. Mallampati S, Pauwels J, Hoogmartens J, Van Schepdael A. 12 CE in impurity profiling of drugs. Sep Sci Technol 2008;9(07):259-315.
  48. Buckau G, Duschner H, Psarros N. Characterization of humic and fulvic acids from Gorleben groundwater.Fresenius J Anal Chem. 1990?338:245–52.
  49. Rajawat J, Jhingan G. Mass spectroscopy. InData Processing Handbook for Complex Biological Data Sources 2019:1-20.
  50. Wennig R. Potential problems with the interpretation of hair  analysis results. Forensic Sci Int 2000;107(1-3):5-12.
  51. Ronowicz J, Kupcewicz B, Myd?owska J, Budzisz E. Impurity profile analysis of drug products containing acetylsalicylic acid: A chemometric approach. Cent Eur J Chem 2013;11(7):1091-1100.
  52. Herderich M, Richling E, Roscher R, Schneider C, Schwab W, Humpf HU. Application  of Atmospheric Pressure Ionisation HPLC-MS-MS for the Analysis of Natural Products. Chromatographia, 1997; 45: 127-32.
  53. Patel KN, Patel JK, Patel MP, Rajput GC, Patel HA. Introduction to Hyphenated Techniques and Their Applications In Pharmacy, Pharm. Methods, 2010; 1(1): 2-13.
  54. Joachim E. The Use of Hyphenated LC–MS Technique for Characterization of Impurity Profiles During Drug Development. J Pharm Biomed Anal, 1998; 18: 707-14.
  55. Jong D, áde Jong GJ, TháBrinkman UA. Investigation of on-line reversed-phase liquid chromatography–gas chromatography mass spectrometry as a tool for the identification of impurities  in drug substances. Analyst 1996;121(1):61-6.
  56. Patel KN, Patel JK, Patel MP, Rajput GC, Patel HA. Introduction to Hyphenated Techniques and Their Applications In Pharmacy. Pharm Method, 2010, 1(1): 1-13.
  57. John CL. Directly Coupled HPLC-NMR and HPLC-NMR-MS in Pharmaceutical Research and Development. J Chromatogr B, 2000; 748: 233-58.
  58. Albert K. On-line LC-NMR and Related Techniques. London: Wiley, 2002.
  59. John CL. Directly Coupled HPLC-NMR and HPLC-NMR-MS in Pharmaceutical Research and Development. J Chromatogr B, 2000; 748: 233-58.
  60. John KR and Richard JS, Use of Liquid Chromatography-Nuclear Magnetic Resonance Spectroscopy for the Identification of Impurities in Drug Substances, J.Chromatogr. A, 1994; 677: 385-89.
  61. Ahuja S, Scypinski S, Handbook of Modern Pharmaceutical Analysis. 1st ed., vol 3, USA; Academic Press, 2001; 149-152.
  62. Norwood DL, Mullis JO, Feinberg TN. 7 Hyphenated techniques. Sep Sci Technol 2007;8:189-235.
  63. Wolfender JL, Rodriguez S, Hostettmann K. Liquid chromatography coupled to mass spectrometry and nuclear magnetic resonance spectroscopy for the screening of plant constituents. J Chromatogr A 1998;794(1-2):299-316.
  64. Stutz H. Advances in the analysis of proteins and peptides by capillary electrophoresis with matrix?assisted laser desorption/ ionization and electrospray?mass spectrometry detection. Electrophoresis 2005;26(7?8):1254-90.
  65. Visky D, Jimidar I, Van Ael W, Vennekens T, Redlich D, De Smet M. Capillary electrophoresis?mass spectrometry in impurity profiling of pharmaceutical products. Electrophoresis 2005;26(7?8):1541-9.
  66. Van Wijk AM, Muijselaar PG, Stegman K, De Jong GJ. Capillary electrophoresis-mass spectrometry for impurity profiling of basic pharmaceuticals using non-volatile  background electrolytes. J Chromatogr A 2007;1159(1-2):175-84.
  67. Scheffel U, Rhodes BA, Natarajan TK, Wagner HN. Albumin microspheres for study of the reticuloendothelial system. J Nucl Med 1972;13(7):498-503.
  68. Guntupalli S, Ray UK, Murali N, Gupta PB, Kumar VJ, Satheesh D, et al. Identification, isolation and characterization of process related impurities in ezetimibe. J Pharm Biomed Anal 2014;88:385-90.
  69. Prakash L, Malipeddi H, Subbaiah BV, Lakka NS. Impurity profiling and stability-indicating UPLC method development and validation for the estimation of related impurities of halobetasol propionate in halobetasol propionate 0.05 % (w/w)  cream. J Chromatogr Sci 2015;53(1):112-21.
  70. Lajin B, Steiner O, Fasshold L, Zangger K, Goessler W. The identification and chromatographic separation of a new highly analogous impurity of the active pharmaceutical ingredient  icatibant. Eur J Pharm Sci 2019;132:121-124.
  71. Kumar V, Bhurta D, Sharma A, Kumar P, Bharate SB, Vishwakarma RA, et al. Impurity profiling of anticancer preclinical candidate, IIIM-290. J Pharm Biomed Anal 2019;166:1-5.
  72. Prakash L, Himaja M, Subbaiah BV, Vasudev R, Srinivasulu C, Haribabu R. Isolation, identification and characterization of degradant impurities in Tolterodine tartrate formulation. J Pharm Biomed Anal 2014;90:215-221.
  73. Zhuang T, Zhang W, Cao L, He K, Wang Y, Li J, et al. Isolation, identification and characterization of two novel process-related impurities in olanzapine. J Pharm Biomed Anal 2018;152:188-96.
  74. Kumar N, Devineni SR, Gajjala PR, Dubey SK, Kumar P. Synthesis, isolation, identification and characterization of new process-related impurity in isoproterenol hydrochloride by HPLC, LC/ESI-MS and NMR. J Pharm Anal 2017;7(6):394-400.
  75. Karthikeyan K, Arularasu GT, Murali V, Pillai KC. Identification, isolation, characterization and response factor determination of process-related impurity in meprobamate drug substance. J Pharm Biomed Anal 2011;54(1):208-212.
  76. Reddy RB, More KR, Gupta L, Jha MS, Magar L. Identification, synthesis, isolation and characterization of new impurity in metoprolol tartrate tablets. J Pharm Biomed Anal 2016;117:104-8.

Photo
Sagar R. Pagade
Corresponding author

Department of Pharmaceutics , Ashokrao Mane Institute of Pharmacy, Ambap-416112, India

Photo
Sahil Agrawal
Co-author

Department of Pharmaceutics , Ashokrao Mane Institute of Pharmacy, Ambap-416112, India

Photo
Prathmesh Shejal
Co-author

Department of Pharmaceutics , Ashokrao Mane Institute of Pharmacy, Ambap-416112, India

Photo
Pranjal Chougule
Co-author

Department of Pharmaceutics , Ashokrao Mane Institute of Pharmacy, Ambap-416112, India

Photo
Nilesh Chougule
Co-author

Department of Pharmaceutics , Ashokrao Mane Institute of Pharmacy, Ambap-416112, India

Sagar Pagade*, Sahil Agrawal, Prathmesh Shejal, Pranjal Chougule, Nilesh Chougule, Detection Of Impurities: A Review On Advance In Impurities Detection And Characterization In Pharmaceuticals By Analytical Techniques, Int. J. in Pharm. Sci., 2023, Vol 1, Issue 12, 860-879. https://doi.org/10.5281/zenodo.10433875

More related articles
The Phytochemical And Pharmacological Review Artic...
Shaikh Mohammadsaad A., Patel Munavvar Y., Shaikh Umed K., Shaikh...
The Surge in Cardiovascular Diseases Post-COVID: P...
Haritha Babu Mm, Prya, Sharanya S., Sharadhi S., Dr. M. Mallikarj...
Navigating the Launching of New Pharmaceutical Pro...
Prajwal Bhadke, Ishwar Kale, Vaishnavi Dere, Aakansha Usare , S...
View more
Formulation And Development Of Bilayer Tablets Of Cimetidine And Sucralfate For ...
Naumaan Naeem shaikh, Pradnya Palekar, Shanbhag Sanjana Jadhav, Samiksha Shinde, Akshaya Aravamudhan...
Formulation And Evaluation Of Emulgel For The Treatment Of Psoriasis...
Abishek jhariya , Nazneen Dubey, Shubhangi Nema, Bharti Choudhary, ...
A Brief Review Of Semecarpus Anacardium Linn ...
Prajakta Darwatkar, Priyanka Bhandari , Akash Doke , Rohit Devdhe , Pratik Dimble, Pratik Borawake, ...
View more
Download PDF
Related Articles
Toxicological Studies of Methanolic Extracts of Ctenolepis garcinii (Burm. f) Us...
Natarajan P., Melba Y., Thiruppathi M., Edwin Jose, Jegan N., ...
Creation And Evaluation Of Multi Herbal Fairness Cream By Using Carica Papaya An...
Manisha U. Mishra , Aishwarya A. Jain, Prachi S. Patle, Pratibha U. Thakur, Priyanshi A. Ramteke, Ri...
Formulation And Evaluation of Red Lentils Herbal Face Scrub...
Kiran Kekane, Akanksha Rayate, Prapti Vikhe, Tejashri Mulay, ...
A Research On Development And Evaluation Of Polyherbal Transdermal Patch With Na...
Shubham Bhaskar Tarle , Vaishnavi A.Chavan, Akash Anil pawar , Rushikesh s. Sonawane, Siddhesh R. ga...
The Phytochemical And Pharmacological Review Article Of Fig Tree (Ficus Carica)...
Shaikh Mohammadsaad A., Patel Munavvar Y., Shaikh Umed K., Shaikh Rayyan J., Quazi Majaz , Aejaz Ahm...
More related articles
The Phytochemical And Pharmacological Review Article Of Fig Tree (Ficus Carica)...
Shaikh Mohammadsaad A., Patel Munavvar Y., Shaikh Umed K., Shaikh Rayyan J., Quazi Majaz , Aejaz Ahm...
The Surge in Cardiovascular Diseases Post-COVID: Prevalence and Incidence Insigh...
Haritha Babu Mm, Prya, Sharanya S., Sharadhi S., Dr. M. Mallikarjuna Gowda, Dr. Satish S., ...
Navigating the Launching of New Pharmaceutical Products: Promotional Challenges ...
Prajwal Bhadke, Ishwar Kale, Vaishnavi Dere, Aakansha Usare , Shubham Kamdi, ...
View more
The Phytochemical And Pharmacological Review Article Of Fig Tree (Ficus Carica)...
Shaikh Mohammadsaad A., Patel Munavvar Y., Shaikh Umed K., Shaikh Rayyan J., Quazi Majaz , Aejaz Ahm...
The Surge in Cardiovascular Diseases Post-COVID: Prevalence and Incidence Insigh...
Haritha Babu Mm, Prya, Sharanya S., Sharadhi S., Dr. M. Mallikarjuna Gowda, Dr. Satish S., ...
Navigating the Launching of New Pharmaceutical Products: Promotional Challenges ...
Prajwal Bhadke, Ishwar Kale, Vaishnavi Dere, Aakansha Usare , Shubham Kamdi, ...
View more

Copyright © 2024 IJPS. All rights reserved